The company celebrates its first anniversary of Hope & Wonder™, a private label brand designed to…
Mes: enero 2023
Cox, Castle & Nicholson LLP Names Commercial Real Estate Finance Attorney Amanda R. Wolin to Partnership
LOS ANGELES–(BUSINESS WIRE)–Cox, Castle & Nicholson LLP, a leading full-service law firm specializing in real estate…
Templeton Global Income Fund (“GIM” or the “Fund”) Announces Distribution and Management Fee Waiver Extension
FORT LAUDERDALE, Fla.–(BUSINESS WIRE)–Templeton Global Income Fund [NYSE: GIM] today announced a monthly distribution from net…
DBRS Morningstar: U.S. ABS 2023 Outlook
NEW YORK–(BUSINESS WIRE)–#ABS–We enter 2023 amid a challenging and uncertain economic backdrop. Thanks in large part…
Templeton Emerging Markets Income Fund (“TEI” or the “Fund”) Announces Distribution
FORT LAUDERDALE, Fla.–(BUSINESS WIRE)–Templeton Emerging Markets Income Fund [NYSE: TEI] today announced a monthly distribution from…
Franklin Universal Trust (“FT” or the “Fund”) Announces Distribution
SAN MATEO, Calif.–(BUSINESS WIRE)–Franklin Universal Trust [NYSE: FT] today announced a monthly distribution from net investment…
BIOLINERX ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against BioLineRx Ltd. and Encourages Investors to Contact the Firm
NEW YORK–(BUSINESS WIRE)–#A–Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that…
G-III ALERT: Bragar Eagel & Squire, P.C. is Investigating G-III Apparel Group, Ltd. on Behalf of G-III Stockholders and Encourages Investors to Contact the Firm
NEW YORK–(BUSINESS WIRE)–#A–Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating…
The Shortcut Announces Its Inaugural CES 2023 Award Winners
Gaming and TV Announcements Rule Supreme With Bigger, Better and More Vibrant Offerings Than Ever Before…
Genexine to Present Final Phase 2 Clinical Data on Its Cervical Cancer Program Showing a 35.0% Overall Response Rate and Provide a Corporate Overview During JP Morgan Conference
SEOUL, South Korea–(BUSINESS WIRE)–Genexine (KOSDAQ: 095700), a publicly traded, clinical-staged Korean biopharmaceutical company committed to the…